ARK Genomic Revolution ETF Rating $42.06 -0.30 (-0.71%) As of 06/30/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.59Holdings in ARKG have an aggregate rating of Moderate Buy based on 333 analyst ratings issued in the past year covering 25 companies (93.7% of the portfolio).ARKG Aggregate Price Target$42.06High Prediction$42.06Average Prediction$42.06Low Prediction$42.06Holdings in ARKG have an aggregate price target of $42.06 and a range of $42.06 to $42.06 covering 25 companies (93.7% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.93%TWSTTwist Bioscience$102.88+4.6%1.3875 of 5 stars2.80$79.30 -22.9%10Positive NewsAnalyst ForecastGap Down7.64%CRSPCRISPR Therapeutics$54.59-3.1%2.601 of 5 stars2.58$67.78 24.2%197.39%TEMTempus AI$57.93-0.7%2.6439 of 5 stars2.50$68.54 18.3%14Trending NewsInsider Trade7.01%TXG10x Genomics$38.34+3.2%1.5822 of 5 stars2.20$24.00 -37.4%155.88%ABSIAbsci$11.59+2.1%1.9022 of 5 stars2.78$12.57 8.5%95.38%PSNLPersonalis$13.40-2.5%1.8479 of 5 stars2.57$11.00 -17.9%7News Coverage4.91%BEAMBeam Therapeutics$34.32-1.8%2.1344 of 5 stars2.71$46.83 36.5%14Insider Trade4.41%GHGuardant Health$150.03-2.4%1.8874 of 5 stars3.00$144.82 -3.5%24Analyst ForecastInsider Trade4.30%ILMNIllumina$175.83-2.9%2.2158 of 5 stars2.32$147.18 -16.3%19Analyst Forecast4.10%NTRANatera$271.45-0.3%1.8275 of 5 stars2.86$260.33 -4.1%22Analyst Forecast3.39%VCYTVeracyte$58.73-2.4%1.6081 of 5 stars2.56$50.43 -14.1%9Analyst Forecast3.16%NTLAIntellia Therapeutics$16.92+1.9%2.7924 of 5 stars2.35$20.46 20.9%23Positive News3.03%CDNACareDx$28.50-2.7%1.2513 of 5 stars2.00$25.00 -12.3%6Insider Trade2.73%CMPSCompass Pathways$14.15-6.1%2.8211 of 5 stars3.00$23.10 63.3%132.69%RXRXRecursion Pharmaceuticals$3.67-0.5%2.936 of 5 stars2.20$8.10 120.7%52.35%ADPTAdaptive Biotechnologies$21.45+0.2%2.7387 of 5 stars2.57$20.50 -4.4%7Positive NewsAnalyst ForecastInsider Trade2.24%SDGRSchrodinger$16.25-6.6%2.7202 of 5 stars2.33$20.25 24.6%9News Coverage2.03%NRIXNurix Therapeutics$24.26+1.7%3.3437 of 5 stars2.81$32.20 32.7%16Analyst Forecast1.97%LLYEli Lilly and Company$1,199.30-2.5%4.3628 of 5 stars2.87$1,235.07 3.0%30Trending News1.92%BFLYButterfly Network$8.40-5.7%1.2759 of 5 stars2.33$5.56 -33.8%61.78%WGSGeneDx$68.65-0.7%4.0915 of 5 stars2.63$87.43 27.4%8Trending NewsAnalyst Forecast1.47%IONSIonis Pharmaceuticals$79.37-1.6%3.1289 of 5 stars2.90$102.90 29.7%21Insider TradeAnalyst Revision1.42%ARCTArcturus Therapeutics$6.72-1.5%2.435 of 5 stars2.67$25.44 278.6%12News Coverage1.31%CERSCerus$2.92-2.3%2.433 of 5 stars2.25$4.00 37.0%4Short Interest Increase1.23%ATAIAtai Beckley$5.27-1.7%3.2182 of 5 stars2.91$16.00 203.6%11 This page (BATS:ARKG) was last updated on 7/1/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
